Cobalt Released From Sepracor Suit Over Sleep Drug

Law360, New York (October 13, 2010, 12:28 PM EDT) -- Cobalt Pharmaceuticals Inc. has become the latest generics maker to reach a resolution with Sepracor Inc. in ongoing litigation accusing a litany of pharmaceutical companies of infringing patents covering the sleep medication Lunesta.

Judge Dennis M. Cavanaugh of the U.S. District Court for the District of New Jersey on Tuesday signed off on a stipulation of dismissal without prejudice between the parties.

Cobalt and Sepracor — which on Tuesday changed its name to Sunovion Pharmaceuticals Inc. — informed Judge Cavanaugh last week that they had reached...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.